title: Heparin in patients with heparin-induced thrombocytopenia type II requiring LVAD implantation and cardiac transplantation.
authors.forename: S
authors.initials: S
authors.lastname: Christiansen
authors.forename: D
authors.initials: D
authors.lastname: Hammel
authors.forename: C
authors.initials: C
authors.lastname: Schmidt
authors.forename: H H
authors.initials: HH
authors.lastname: Scheld
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D002311:Cardiomyopathy, Dilated / Q000628:therapy; D002315:Cardiopulmonary Bypass; D003657:Decision Making; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced; D016027:Heart Transplantation; D006352:Heart Ventricles; D006353:Heart-Assist Devices; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000628:therapy; D013921:Thrombocytopenia / Q000139:chemically induced*; D013927:Thrombosis / Q000139:chemically induced
chemical_list: D000925:Anticoagulants; D006493:Heparin